Bio-Rad Acquires GnuBio for Undisclosed Sum

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1 Kendall Square Bldg 1400 Cambridge, MA 02139 USA
  • Company Description
    GnuBIO is a genomics company developing next-generation sequencing technology for the molecular diagnostic and applied research markets. The GnuBIO system is based on emulsion and microfluidic technology developed at Harvard University.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the deal were not disclosed.

Trending on Xconomy